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Comparison of neutral oral contrast versus
positive oral contrast medium in abdominal
multidetector CT
Abstract To determine whether
neutral contrast agents with water-
equivalent intraluminal attenuation
can improve delineation of the bowel
wall and increase overall image qual-
ity for a non-selected patient popula-
tion, a neutral oral contrast agent (3%
mannitol) was administered to 100
patients referred for abdominal multi-
detector row computed tomography
(MDCT). Their results were compared
with those of 100 patients given a
positive oral contrast agent. Qualita-
tive and quantitative measurements
were done on different levels of the
gastrointestinal tract by three experi-
enced readers. Patients given the
neutral oral contrast agent showed
significant better qualitative results for
bowel distension (P<0.001), homo-
geneity of the luminal content
(P<0.001), delineation of the bowel-
wall to the lumen (P<0.001) and to
the mesentery (P<0.001) and artifacts
(P<0.001), leading to a significant
better overall image quality (P<
0.001) than patients receiving positive
oral contrast medium. The quantitative
measurements revealed significant
better distension (P<0.001) and wall
to lumen delineation (P<0.001) for
the patients receiving neutral oral
contrast medium. The present results
show that the neutral oral contrast
agent (mannitol) produced better dis-
tension, better homogeneity and better
delineation of the bowel wall leading
to a higher overall image quality than
the positive oral contrast medium in a
non-selected patient population.
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Introduction
Recent advances in multidetector row computed tomogra-
phy (MDCT) have led to a paradigm shift in the diagnostic
approach to abdominal imaging, especially of the vascular
system and solid organs [1–3]. The ability of MDCT to
acquire imaging data with near isotropic voxel size allows
for high-quality reconstruction in any possible viewing
plane. The new display methods help to better commu-
nicate the diagnostic information in a way that is more
understandable to the referring physicians. However, they
have also changed the way imaging of the gastrointestinal
tract (GIT) is perceived. The standardGIT distensionmethod
for MDCT of the abdomen employs high-attenuation
contrast agents [diluted iodine (DI) or barium suspension]
to labelmainly the stomach and small bowel.With the advent
of the new techniques, the use of high-attenuation GIT
distension material should to be re-evaluated since it may
degrade the image quality in procedures requiring maximum
intensity reconstruction for abdominal MDCT angiography
[4]. More importantly, it may fail to provide adequate mural
enhancement for diagnosis of GIT abnormalities due to the
almost non-existent difference between the enhanced bowel
wall and the high-attenuation intraluminal content. Ideally,
an oral contrast medium should have a high distension
capability that delivers optimal differentiation between
lumen and bowel wall.
Neutral intraluminal contrast agents could produce
improved image quality and facilitate the diagnosis of
GITwall abnormalities since their attenuation of the bowel
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lumen approaches that of water. Neutral agents have
proved to be effective in the diagnosis of Crohn’s disease
[5–7], neoplasms [8], and bowel-ischemia [9]. They are
also used to distend and delineate the stomach and
duodenum in imaging of pancreatic and biliary disease
[10, 11]. The most widely used neutral contrast agent is
water. It has excellent contrast behaviour in the upper
GIT. Its clinical use for the distal parts of the small
bowel, however, is limited due to its rapid absorption
[10–15]. Additives can slow the absorption of water by
increasing the osmolarity [16, 17]. One such additive is
mannitol, an inexpensive and easy-to-use neutral oral
contrast agent. To the best of our knowledge, mannitol
has never been tested for abdominal MDCT imaging in a
large group of non-selected patient poulation, although it
has been tested for selected patients with small bowel
disease [16].
We compared the image quality of an orally adminis-
tered neutral contrast agent (3% mannitol) with that of a
positive oral contrast agent (3% DI) in MDCT of the
abdomen and pelvis.
Materials and methods
Patients
A total of 200 consecutive patients (101 male, 99 female)
referred to our department between January 2004 and May
2004 for MDCT of the abdomen and pelvis with intrave-
nous contrast enhancement were studied. The indications
for MDCT in both groups did not differ statistically with
regard to their distribution (chi-square test). The study was
approved by our Institutional Review Board.
Patients were divided into two groups of 100 patients
each. The patients were randomly selected by a predefined
list to participate in either of the two groups. The neutral
oral contrast group (50 men, 50 women; mean age: 62.6±
13.7 years) was given a 3% mannitol preparation, the
positive oral contrast group (51 men, 49 women; mean age:
60.6±17 years) a 3%DI solution. There were no significant
intergroup differences regarding gender distribution (chi-
square test) or age (Student’s t-test).
The indication for the MDCT examination was as
follows: oncology 53%/56% (neutral contrast group/DI
group respectively), emergency radiology 29% and 28%
and surgical evaluation, either preoperatively or post-
operatively 18% for both groups.
Preparation of oral contrast agents
Administration of the contrast agents was standardized.
The patients in each group received 1,000 ml of liquid
contrast solution mixed shortly before use. All the patients
were instructed to drink the whole amount regularly over a
60-min period while remaining in a supervised area in our
department where all potential side effects and complaints
could be monitored by the nursing staff, such as vomiting,
abdominal pain, diarrhea and allergic reactions.
The positive oral contrast group was given a 3% DI
solution consisting of 30 ml of megluminioxitalamat
(Telebrix Gastro, Guerbet, France) diluted in 970 ml of
tap water according to our clinical routine. Megluminiox-
italamat contains 300 mg/ml iodine according to our
clinical routine.
The neutral oral contrast group received a solution of 3%
mannitol, which consists of 30 g of mannit sugar dissolved
in 1,000 ml of tap water. This solution is well known from
its application in abdominal magnetic resonance imaging
(MRI) as published in previous studies [18].
Before imaging an intravenous line was placed in all
patients. The patients were placed head first and supine on
the CT table. While on the table they received rectal
contrast medium consisting of 500 ml 3% DI according to
our standard clinical protocol.
Imaging
All examinations were performed on a 16-detector row
MDCT scanner (Brilliance, Philips Imaging System, The
Netherlands). A power injector (Tomojet, Doltron, Switzer-
land) administered 120 ml of intravenous contrast material
at a concentration of 300 mg/ml iodine [Ultravist 300
(Bayer-Schering, Germany), Xenetix 300 (Guerbet,
France) or Imagopaque 300 (GE, USA)] with an injection
rate of 1.5–2.5 ml/s. The administration of contrast was
followed by a flush of 50 ml normal saline at the same
injection rate. After coronal scout images were obtained,
intravenous contrast bolus was initiated, followed 60–90 s
later by single phase acquisition from the xiphoid to the
symphysis using a 16×1.5-mm detector configuration,
creating 5-mm transverse sections. Coronal reconstructions
3-mm thick were automatically generated by the computer
from the anterior abdominal wall to the paravertebral
muscles (Fig. 1).
Image analysis
Three experienced radiologists (R.B., M.A.P., B.E.), each
with more than 6 years experience in body imaging,
independently reviewed the images from each examination
in transverse and coronal planes on a picture archiving and
communication system workstation (AGFA, Japan). Be-
cause high-attenuation contrast was being compared to
neutral intraluminal contrast, it was impossible to blind the
readers to the oral contrast agent administered. All
reviewers were blinded to the clinical history.
An incremental five-point scale (0=worst, 4=best) was
used to rate images from each examination for bowel
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distension, homogeneity of the lumen, delineation of the
bowel wall, presence of artifacts and overall image quality.
Overall bowel distention was graded from totally
collapsed (0) to maximal distension (4); homogeneity of
the lumen from massively inhomogeneous (0) to com-
pletely homogeneous (4). The delineation of the bowel
wall was rated twice from indiscernible (0) to clearly
visible (4), once against the intraluminal contrast and once
against the surrounding extraintestinal tissue. The presence
of artifacts ran from no artifacts (0) to serious image
degradation due to artifacts (4). Finally, overall image
quality was assessed from unreadable (0) to perfect (4).
To prove the aspects seen in the qualitative evaluation,
additional quantitative measurements were performed by
one of the researchers (R.B.) at least 2 weeks apart from the
qualitative reading. The maximum cross-sectional diameter
of the antrum of the stomach, horizontal part of the
duodenum, proximal jejunum, and terminal ileum were
measured perpendicular to the axis of the lumen using the
outer margins of the intestinal wall for each patient.
Attenuation [in Hounsfield units (HU)] of the lumen and
gastrointestinal wall was measured at the same levels of the
stomach, duodenum, jejunum, and terminal ileum. Atten-
uation of the lumen was measured by placing a region of
interest (ROI) within a well-distended segment of the small
bowel section. Attenuation of the wall was measured by
first zooming into the image section until the wall was
clearly visible, then placing an ROI over the bowel wall.
The ROI had to have a minimal diameter of 2 mm.
For each measured section of the GIT, the contrast for
the bowel wall was calculated as the difference in
attenuation values (contrast) of the lumen and wall by
subtracting the HU value obtained from the lumen from the
HU value obtained from the corresponding gastrointestinal
wall.
Statistical analysis
For all readers, the Mann-Whitney U-test was used to
perform statistical analysis of the differences in median
scores between the neutral oral contrast and positive oral
contrast groups regarding bowel distention, homogeneity
of the lumen, differentiation of the bowel wall against
luminal content and surrounding fat, the presence of
artifacts and overall image quality. Differences were
considered significant if P<0.05. Inter-observer agreement
was evaluated using linear-weighted kappa statistics where
a kappa statistic >0.75 was considered as excellent
agreement, 0.4–0.75 as fair to good agreement, and <0.4
as poor agreement [19]. Values near zero or less than zero
reflected only chance agreement.
Regarding the quantitative analysis, the differences in
maximum diameters, HU values for the GIT lumen, and
contrast values between the neutral oral contrast and
positive oral contrast groups were compared using
Student’s unpaired t-test. Differences were considered
significant if P<0.05.
Results
All patients tolerated the administration of oral contrast
well, there was no vomiting, diarrhea, abdominal pain nor
Fig. 1 Coronal reformation im-
ages of abdominal MDCT after
oral administration of neutral
(mannitol) (a) or positive (me-
gluminioxitalamat) contrast (b).
Direct comparison shows a
marked and constant distension
of the lumen with uniform at-
tenuation in the neutral contrast
prepared patient (a), and pro-
nounced and increasing luminal
attenuation in the positive con-
trast prepared patient (b)
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allergic reactions to both oral contrast. There were no
serious side effects. All patients drank the designated
amount of fluid within the given time span. MDCT could
be obtained without major side effects in both groups.
Qualitative evaluation
The images were of sufficient quality to be evaluated, for a
total of 200 assessed MDCT scans. The individual
qualitative results for all readers are summarized in
Fig. 2. The inter-observer variability was fair to good
with kappa values of 0.44–0.67.
The distension of the entire small bowel, homogeneity of
the applied contrast medium, detection of the internal and
external borders of the bowel wall, and the rate of artifacts
were judged to be significantly better (P<0.001) for the
neutral oral contrast images than the positive oral contrast
images. Also, the overall quality was adjudged to be
significantly better (P<0.001) for the neutral oral contrast
group than for the positive oral contrast group.
The inter-observer variability was moderate to good for
all sites with a high significance (P<0.001) for all sites.
Quantitative measurement
The findings on all measurements are summarized in
Table 1. The mean diameter of the antrum of the stomach
measured 6.7 cm for neutral oral contrast group and 6.2 cm
for the positive oral contrast group, not a significant
difference. For all other locations, however, the diameter
was significantly wider for the neutral oral contrast group.
Attenuation of the bowel wall showed no significant inter-
group difference in HU measurements at all locations. As
expected, attenuation of the lumen at the level of the
Fig. 2 Qualitative analysis of the MDCT images of 200 patients
receiving either neutral (mannitol) (n=100) or positive (DI) (n=100)
oral contrast medium. The images were evaluated for bowel
distension, homogeneity of the lumen, delineation of the bowel
wall, rate of artifacts, and overall image quality on axial as well as
on coronal reconstructions by three experienced readers applying a
five-point scale. Qualitative analysis of MDCT of 200 patients
receiving either neutral (mannitol) (n=100) or positive (diluted
iodine) (n=100) oral contrast medium. The images were evaluated
for bowel distension, homogeneity of the lumen, delineation of the
bowel wall, rate of artifacts, and overall image quality on axial as
well as on coronal reconstructions by 3 experienced readers
applying a 5-point scale. The median score for each reader for a
given evaluation location is shown, with the range in parenthesis.
For each reader, all qualitative assessments were significantly better
for the neutral contrast (mannitol) group as indicated by the p values
using the unpaired Student’s t-test
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stomach, duodenum, jejunum, and terminal ileum was
significantly higher in the positive oral contrast group
receiving DI.
A significantly higher difference between the bowel wall
attenuation and the luminal content was calculated for the
neutral contrast group compared to the positive oral
contrast group (P<0.001).
Discussion
The use of neutral oral contrast agents for CT enterography
has been described by many authors [20–22]. These
authors used neutral contrast agents specifically to
investigate small bowel diseases, such as Cohn’s disease,
or for tumour staging. If the focus lay on other organs, they
preferred positive intraluminal contrast to better distinguish
small bowel structures from other organs, or intraluminal
fluid from fluid collections outside the bowel.
There is rising interest in the use of neutral contrast
agents for a wider range of indications or even routinely. In
this context, a study of VoLumen (E-Z-EM, Lake Success,
N.Y.), a commercially available, low attenuation contrast
agent, reported good bowel distention and good visualiza-
tion of the bowel wall [23]. Many aspects of mannitol
resemble those of VoLumen. They are both definitely better
than water for distension and conspicuity of the bowel wall.
They also have a low side-effect profile. The main
difference concerns the densities: due to its lower barium
(0.1%) content, VoLumen has slightly higher HU than
mannitol (20–40 HU versus 0–10 HU). This can be helpful
in depicting extraluminal pathologies, which often have the
same attenuation as water.
With positive oral contrast agents, subtle changes in the
bowel wall and its surrounding fat can be masked. The
reasons for this are (1) the enhanced bowel wall may have
the same attenuation as the positive contrast of the lumen
and (2) because areas of high densities often occur due to
heterogeneous intraluminal distribution, leading to artifacts
with reduced visualization of the bowel wall and surround-
ing fat (Fig. 3).
The technical advances in MDCT technology, with high
resolution image acquisition, multiplanar reconstruction,
and computer workstations for anatomical reconstruction
have made it possible to interpret every structure in
abdominal CT studies, including organs, vessels, bones and
also bowel, in a single examination (Fig. 4).
The ability of workstations to reconstruct anatomical
details in every desirable plane has made it much easier to
differentiate between the bowel and surrounding structures,
as well as between intraluminal and extraluminal fluid.
Orally administered neutral luminal contrast medium leads
to good visualization of small bowel structures, clearly
delineating lesions and even the normal bowel wall, the
blood supply, and the status of the surrounding fat tissue [4,
5] without hampering the examination of other organs. The
differentiation of extraluminal fluid could be difficult with
neutral oral contrast medium. The above mentioned ability
of multiplanar reconstruction compensates this drawback.
Therefore neutral oral contrast agents, preferably those
Table 1 Quantitative measurements of MDCT images of 200 patients receiving either neutral (mannitol) (n=100) or positive (DI) (n=100)
oral contrast medium. The diameter and attenuation of the lumen and bowel wall were measured at different levels of the small bowel
Location Oral contrast Diameter
(cm)
Attenuation of bowel wall
(HU)
Attenuation of bowel lumen
(HU)
Difference wall
to lumen
Stomach Neutral contrast
(mannitol)
6.7 69.3 2.3 67.0
Positive contrast (DI) 6.2 63.7 95.4 -31.8
0.35 0.05 <0.001 <0.001
Duodenum Neutral contrast
(mannitol)
2.4 74.0 3.1 70.6
Positive contrast (DI) 1.9 67.9 86.3 -18.5
<0.001 0.15 < 0.001 <0.001
Jejunum Neutral contrast
(mannitol)
2.1 67.1 6.8 60.3
Positive contrast (DI) 1.8 67.4 112.9 -45.4
<0.001 0.85 <0.001 <0.001
Terminal
ileum
Neutral contrast
(mannitol)
1.8 56.0 5.9 50.2
Positive contrast (DI) 1.5 60.3 205.4 -145.1
<0.001 0.05 <0.001 <0.001
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providing good distention of the bowel, merit routine
application (Fig. 5).
Water as neutral contrast agent is quickly absorbed in the
GIT, leading to insufficient bowel distention throughout
[13]. We, therefore, used a 3% mannitol solution in the
expectation that mannitol’s slight osmotic effect would
produce better distention. This contrast agent is used at
some institutions as part of a routine MR protocol for the
examination of the small bowel, providing good small
bowel distension without absorption [8, 9, 14, 24].
One of the main goals of the present study was,
therefore, to compare small bowel distention after oral
administration of a 3% mannitol-based contrast to that
following oral administration of a positive 3% DI-based
contrast agent. For this purpose calculation of the whole
small-bowel volume would be best, but no such technique is
yet available. Quantitative measurement of the bowel
diameter at different segments, considering the length of
the small bowel, can only give an approximation of the
overall distention. By choosing reproducible sites along the
GIT at the level of the stomach (widest part), horizontal part
of the duodenum (widest part), the proximal jejunum, and
terminal ileum, we were able to compare our measurements.
We found significantly better distension of the small
bowel with the neutral contrast (mannitol) than with the
positive contrast (DI). The quantitative measurements were
confirmed by the qualitative results by the three readers,
with moderate to good inter-observer correlation. The
diameter of the stomach did not differ significantly
between the two contrast agent groups.
The results of the better distension can be explained by
the higher osmotic effect of mannitol compared with DI.
The water that is administered with the mannitol solution
and the physiologic fluids secretion of the upper GI tract
are retained by the high osmotic effect of the mannit sugar,
which itself is non-digestible by the human body. On the
other hand, DI has only a slight osmotic effect, therefore
fluid is absorbed during the passage in the bowel and the
distension is decreasing for the more distal bowel sections.
The increase in attenuation of the bowel content can be
explained by absorbtion of water and increasing concen-
tration of iodine in the remaining water.
The quantitative analysis was performed by measuring
the attenuation of the bowel wall and the attenuation of the
fluid in the lumen at the locations mentioned above.
Technical challenges occurred if the intraluminal fluid was
too concentrated, thereby masking the bowel wall and
leading to artifacts (Fig. 6). The difference in attenuation
between the intraluminal fluid and enhanced bowel wall is
the degree of bowel wall contrast. In our patients, the
Fig. 4 Coronal maximum intensity projection (MIP) of abdominal
MDCT in a 54-year-old woman after oral preparation with neutral
contrast (mannitol). Note the well-extended small bowel. The
neutral contrast medium in the small bowel allowed for easy MIP
reconstruction, leading to better demonstration of the vessels than
would have been the case with positive intraluminal contrast
medium
Fig. 3 Enlarged section of an axial plane of abdominal MDCT in a
57-year-old woman after oral preparation with neutral contrast
medium (mannitol). The image shows Crohn’s disease with
intraabdominal abscesses (arrowhead), inflammation of the small
bowel with markedly thickened wall (arrow). There is good contrast
between intraluminal fluid and bowel wall. Note especially the
strong mucosal enhancement
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neutral contrast agent led to very similar neutral fluid
attenuation over the entire length of the small bowel,
providing a homogeneous image. The neutral agent
produced significantly better delineation of the enhanced
bowel wall in the duodenum, jejunum and in the stomach,
with contrast differences of 60–70 HU. Again, the three
readers provided qualitative confirmation of the results
with good inter-observer correlation.
For the terminal ileum the positive oral contrast group
showed a high average contrast difference of 145 HU
between the luminal fluid versus the wall. Instead of the
expected good visualization of the wall, however, artifacts
caused by these high intraluminal contrast levels made
evaluation of the wall in this segment difficult.
Even with the increasing luminal attenuation from the
proximal to the distal small bowel in the neutral oral
contrast medium group the oral contrast material applica-
tion resulted in a homogeneous luminal contrast through-
out to small bowel compared with the positive contrast.
One reason for this may have been the inconsistent rate of
oral uptake. Although the patients were told to drink the
contrast agent regularly over a 60-min period, they may
have tended initially to drink too fast. However, since the
effect was seen in almost all patients, osmotic dilution
appears to have occurred as well.
Interestingly, there was a strong trend in the difference
of the attenuations of the bowel wall at the level of
the stomach and the terminal ileum. At the level of the
stomach, there was a higher attenuation of the wall in the
mannitol group compared wiyh the DI group, whereas it
showed a higher attenuation at the terminal ileum within
the DI group compared with the mannitol group. There is
no clear explanation for this phenomenon since it is
inconsistent for the different patient groups.
The overall image quality was judged to be slightly
better in the neutral oral contrast group, with an
undiminished ability to achieve a diagnosis.
Conclusion
The use of a neutral oral contrast agent led to good image
quality with better distension of the small bowel and
Fig. 6 Coronal plane of abdominal MDCT in a 54-year-old woman,
prepared with orally administered positive contrast medium
(Megluminioxitalamat, Telebrix Gastro, Guerbet, France). Hetero-
ogeneous attenuation of the intraluminal fluid is evident, with
increasing attenuation from the proximal small bowel (arrow) to the
ileum (arrowhead). In the proximal small bowel, the bowel wall
cannot be differentiated since the attenuation of the bowel wall
matches that of the intraluminal fluid (85 HU). High intraluminal
attenuation (303 HU) hampered evaluation of the bowel wall in the
distal part of the small bowel
Fig. 5 Coronal plane of abdominal MDCT in a 37-year-old woman
with diverticulitis presenting with circular thickening of the colonic
wall and focal fatty infiltration (thickened colon displayed axial,
arrowhead) following oral administration of neutral contrast medi-
um (mannitol). The small bowel is well distended over its entire
length with homogeneous attenuation of the luminal fluid. The small
bowel wall is clearly differentiated, including the valvulae
conniventes (arrow). There are no artifacts
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greater delineation of the bowel wall compared with the
positive oral contrast agent. The neutral oral contrast did
not mask the bowel wall as occurred with the positive oral
contrast. Combined with state-of-the-art MDCT systems
and workstations that allow reconstruction of lesions in
every desired plane, neutral oral contrast agents can
facilitate accurate diagnosis of lesions of the GIT. Based
on the present results, they appear to be suited for the
diagnosis in unselected patients.
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